Shrikant Akolkar
Stock Analyst at Nuvama
(2.29)
# 2,976
Out of 4,423 analysts
8
Total ratings
50%
Success rate
7.3%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Shrikant Akolkar
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NSE: CIPLA Cipla Limited | Maintained: Sell | n/a | $1,351.80 | - | 3 | Jan 27, 2026 | |
| NSE: AUROPHARMA Aurobindo Pharma Limited | Maintained: Buy | ₹1,485 → ₹1,460 | $1,497.80 | -2.52% | 2 | Jun 27, 2025 | |
| NSE: JUBLPHARMA Jubilant Pharmova Limited | Maintained: Buy | ₹1,385 | $966.35 | +43.32% | 1 | Jun 27, 2025 | |
| NSE: LUPIN Lupin Limited | Maintained: Buy | ₹2,530 | $2,352.30 | +7.55% | 1 | Jun 27, 2025 | |
| NSE: DRREDDY Dr. Reddy's Laboratories Limited | Upgraded: Buy | ₹1,553 | $1,272.10 | n/a | 1 | Jan 7, 2025 |
Cipla Limited
Jan 27, 2026
Maintained: Sell
Price Target: n/a
Current: $1,351.80
Upside: -
Aurobindo Pharma Limited
Jun 27, 2025
Maintained: Buy
Price Target: ₹1,485 → ₹1,460
Current: $1,497.80
Upside: -2.52%
Jubilant Pharmova Limited
Jun 27, 2025
Maintained: Buy
Price Target: ₹1,385
Current: $966.35
Upside: +43.32%
Lupin Limited
Jun 27, 2025
Maintained: Buy
Price Target: ₹2,530
Current: $2,352.30
Upside: +7.55%
Dr. Reddy's Laboratories Limited
Jan 7, 2025
Upgraded: Buy
Price Target: ₹1,553
Current: $1,272.10
Upside: n/a